RVW Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.84M Buy
4,187
+2,027
+94% +$2.39M 0.31% 45
2026
Q2
$2.59M Buy
2,160
+968
+81% +$989K 0.17% 60
2026
Q1
$1.1M Sell
1,192
-1,000
-46% -$1.01M 0.09% 70
2025
Q4
$2.36M Buy
2,192
+999
+84% +$955K 0.18% 54
2025
Q3
$910K Buy
+1,193
New +$888K 0.07% 75
2023
Q4
– Sell
-86
Closed -$46.2K – 261
2023
Q3
$46.2K Buy
+86
New +$44.3K 0.01% 245

Other funds holding LLY

RVW Wealth's LLY Position: Q3 2026 in Review

RVW Wealth increased its Eli Lilly (LLY) stake by 94% in Q3 2026, buying an estimated $2.39M and bringing the position to 4,187 shares worth $4.84M. The position accounts for 0.31% of the portfolio, ranked #45.

RVW Wealth first reported a position in LLY in Q3 2023 and has held it in 6 quarters since. 983 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • RVW Wealth held 4,187 shares of Eli Lilly worth $4.84M as of Q3 2026.
  • RVW Wealth bought 2,027 Eli Lilly shares in Q3 2026, an estimated $2.39M.
  • Eli Lilly made up 0.31% of RVW Wealth's portfolio in Q3 2026, its #45 holding.
  • RVW Wealth first reported a position in Eli Lilly in Q3 2023 and has held it in 6 quarters since.
  • 983 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on RVW Wealth's 13F filing for Q3 2026, filed 6 Oct 2026.